Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach

Abstract Monkeypox virus (MPXV), a zoonotic pathogen, re-emerged in 2022 with the Clade IIb variant, raising global health concerns due to its unprecedented spread in non-endemic regions. Recent studies have shown that Clade IIb (2022 MPXV) is marked by unique genomic mutations and epidemiological b...

Full description

Saved in:
Bibliographic Details
Main Authors: Joy Prokash Debnath, Kabir Hossen, Sabrina Bintay Sayed, Md. Sayeam Khandaker, Preonath Chondrow Dev, Saifuddin Sarker, Tanvir Hossain
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-80519-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849773862014681088
author Joy Prokash Debnath
Kabir Hossen
Sabrina Bintay Sayed
Md. Sayeam Khandaker
Preonath Chondrow Dev
Saifuddin Sarker
Tanvir Hossain
author_facet Joy Prokash Debnath
Kabir Hossen
Sabrina Bintay Sayed
Md. Sayeam Khandaker
Preonath Chondrow Dev
Saifuddin Sarker
Tanvir Hossain
author_sort Joy Prokash Debnath
collection DOAJ
description Abstract Monkeypox virus (MPXV), a zoonotic pathogen, re-emerged in 2022 with the Clade IIb variant, raising global health concerns due to its unprecedented spread in non-endemic regions. Recent studies have shown that Clade IIb (2022 MPXV) is marked by unique genomic mutations and epidemiological behaviors, suggesting variations in host-virus interactions. This study aimed to identify the differentially expressed genes (DEGs) induced by the 2022 MPXV infection through comprehensive bioinformatics analyses of microarray and RNA-Seq datasets from post-infected cell types with different MPXV clades. Subsequently, gene expression network analyses pinpoint the key DEGs, followed by their candidate drug assessment using the Drug SIGnatures DataBase (DSigDB) and validation by multiple machine learning algorithms. Comparative differential gene expression (DGE) analysis revealed 798 DEGs exclusive to the 2022 MPXV invasion in the skin cell types (keratinocytes). Intriguingly, 13 key DEGs were identified across hubs and clusters, highlighting their aberrant expressions in cell cycle regulation, immune responses, and cancer pathways. Biomarker screening via Random Forest (RF) model (selected with PyCaret from multiple models) and validation through t-distributed stochastic neighbor embedding (t-SNE) algorithm, principal component analysis (PCA), and ROC curve analysis employing Logistic Regression and Random Forest, identified 6 key DEGs (TXNRD1, CCNB1, BUB1, CDC20, BUB1B, and CCNA2) as promising biomarkers (AUC > 0.7) for clade IIb infection. This study anticipates that further investigation and clinical trials will catalyze novel detection and therapeutic options to combat 2022 MPXV infection in humans.
format Article
id doaj-art-c9b0afaaad9546d7920d2c34712bf0c7
institution DOAJ
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-c9b0afaaad9546d7920d2c34712bf0c72025-08-20T03:01:55ZengNature PortfolioScientific Reports2045-23222025-01-0115111510.1038/s41598-024-80519-7Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approachJoy Prokash Debnath0Kabir Hossen1Sabrina Bintay Sayed2Md. Sayeam Khandaker3Preonath Chondrow Dev4Saifuddin Sarker5Tanvir Hossain6Department of Biochemistry and Molecular Biology, Shahjalal University of Science and TechnologyDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and TechnologyDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and TechnologyDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and TechnologyChild Health Research FoundationClinical Laboratory, Medi Check Medical Service LimitedDepartment of Biochemistry and Molecular Biology, Shahjalal University of Science and TechnologyAbstract Monkeypox virus (MPXV), a zoonotic pathogen, re-emerged in 2022 with the Clade IIb variant, raising global health concerns due to its unprecedented spread in non-endemic regions. Recent studies have shown that Clade IIb (2022 MPXV) is marked by unique genomic mutations and epidemiological behaviors, suggesting variations in host-virus interactions. This study aimed to identify the differentially expressed genes (DEGs) induced by the 2022 MPXV infection through comprehensive bioinformatics analyses of microarray and RNA-Seq datasets from post-infected cell types with different MPXV clades. Subsequently, gene expression network analyses pinpoint the key DEGs, followed by their candidate drug assessment using the Drug SIGnatures DataBase (DSigDB) and validation by multiple machine learning algorithms. Comparative differential gene expression (DGE) analysis revealed 798 DEGs exclusive to the 2022 MPXV invasion in the skin cell types (keratinocytes). Intriguingly, 13 key DEGs were identified across hubs and clusters, highlighting their aberrant expressions in cell cycle regulation, immune responses, and cancer pathways. Biomarker screening via Random Forest (RF) model (selected with PyCaret from multiple models) and validation through t-distributed stochastic neighbor embedding (t-SNE) algorithm, principal component analysis (PCA), and ROC curve analysis employing Logistic Regression and Random Forest, identified 6 key DEGs (TXNRD1, CCNB1, BUB1, CDC20, BUB1B, and CCNA2) as promising biomarkers (AUC > 0.7) for clade IIb infection. This study anticipates that further investigation and clinical trials will catalyze novel detection and therapeutic options to combat 2022 MPXV infection in humans.https://doi.org/10.1038/s41598-024-80519-7Mpox (monkeypox)2022 MPXV (Clade IIb)DEGsMachine learning (ML) modelsBiomarkerCandidate drugs
spellingShingle Joy Prokash Debnath
Kabir Hossen
Sabrina Bintay Sayed
Md. Sayeam Khandaker
Preonath Chondrow Dev
Saifuddin Sarker
Tanvir Hossain
Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach
Scientific Reports
Mpox (monkeypox)
2022 MPXV (Clade IIb)
DEGs
Machine learning (ML) models
Biomarker
Candidate drugs
title Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach
title_full Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach
title_fullStr Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach
title_full_unstemmed Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach
title_short Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach
title_sort identification of potential biomarkers for 2022 mpox virus infection a transcriptomic network analysis and machine learning approach
topic Mpox (monkeypox)
2022 MPXV (Clade IIb)
DEGs
Machine learning (ML) models
Biomarker
Candidate drugs
url https://doi.org/10.1038/s41598-024-80519-7
work_keys_str_mv AT joyprokashdebnath identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach
AT kabirhossen identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach
AT sabrinabintaysayed identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach
AT mdsayeamkhandaker identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach
AT preonathchondrowdev identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach
AT saifuddinsarker identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach
AT tanvirhossain identificationofpotentialbiomarkersfor2022mpoxvirusinfectionatranscriptomicnetworkanalysisandmachinelearningapproach